Reducing hospital readmission is an important goal to optimize poststroke care and reduce costs. Early outpatient follow-up may represent one important strategy to reduce readmissions. We examined the association between time to first outpatient contact and readmission to inform postdischarge transitions.
R
educing hospital readmission is a focus of national quality initiatives designed to minimize costs of care and the burden of disease. 1 The annual cost of unplanned rehospitalizations has been estimated at >$17 billion for Medicare alone 2 ; thus, this focus is likely to sharpen as public reporting of readmission data becomes more common and as financial incentives for reducing readmissions increase. Stroke readmissions are a priority because they are common (estimated 17% at 30 days and 42% at 1 year) and associated with high mortality, morbidity, and cost. 3, 4 Studies have identified many potential factors associated with hospital readmissions after a stroke, including but not limited to demographics (ie, age, sex, and race), comorbidities (ie, cardiovascular disease and past stroke), hospital and hospitalization characteristics (ie, length of stay, discharge location, inpatient complications, and rehabilitation intensity), and stroke characteristics (ie, National Institutes of Health stroke scale). [5] [6] [7] [8] [9] [10] [11] [12] [13] However, patientand system-level factors associated with readmission have been inconsistent across studies 1 ; thus, our understanding of inpatient and outpatient practices, which might prevent readmissions, is incomplete.
One strategy to reduce readmissions focuses on optimizing transitional care during the immediate postdischarge period. The transition between inpatient and outpatient care represents an especially vulnerable period for poststroke patients who are often elderly with multiple complex chronic conditions, have extensive care needs, and are accommodating new disability. The set of actions necessary to ensure coordination and continuity of care as patients transfer between locations and levels of care is complex, and little is known about how to best facilitate transitions. 14, 15 Interventions designed to optimize transitional care might reduce undesirable outcomes, such as readmission, by ensuring rapid follow-up of diagnostic testing, improving secondary prevention, coordinating rehabilitative therapies, detecting and treating new symptoms after discharge, and addressing social needs of patient and caregivers. Current guidelines provide little information regarding follow-up time and more broadly the optimal set of interventions to reduce readmissions. 16 Clinical studies in patients recently hospitalized for heart failure, general medical conditions, or various surgeries have suggested that early outpatient provider contact after hospital discharge may improve outcomes and reduce readmissions. [17] [18] [19] However, comparing across disorders is challenging. We, therefore, sought to assess the association between early outpatient postdischarge follow-up and hospital readmissions to determine whether early outpatient physician contact with a primary care physician or neurologist is associated with lower 30-day readmissions after an acute ischemic stroke. These data may inform future readmissionreduction initiatives and improve our understanding of the relative contributions of inpatient and outpatient care on readmissions.
METHODS
The analytic methods, including Stata code, have been made available to other researchers for purposes of reproducing our results or replicating our procedures. 20 Because of the sensitive nature of the data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to the Research Data Assistance Center at https://www.resdac.org/ about-resdac/contact-us.
Study Design and Patient Selection
We performed a retrospective cohort study of all Medicare fee-for-service beneficiaries ≥65 years discharged directly home after an acute ischemic stroke between January and November 2012. Patients were included only if they were admitted within the first 11 months of 2012 to ensure that at least 30 days were available to identify readmissions. Potential subjects were identified if they had an acute inpatient hospitalization, with a primary discharge diagnosis of ischemic stroke (International Classification of Diseases, Ninth Revision, Clinical Modification 433.x1, 434.x1, and 436). [21] [22] [23] [24] Subjects were included if the index hospitalization occurred in a short-stay hospital (identified using Medicare provider numbers) and if patients were discharged directly to home. We excluded patients discharged to postacute care facilities (ie, acute and subacute rehabilitation facility or long-term hospital) for many reasons. (1) There is considerably more variation in stroke severity and other markers of disease severity in patients discharged to institutional rehabilitation setting than to patients discharged home. 25 Given that severity is a likely predictor of which patients have early outpatient visits, our approach of focusing on discharge home is a strategy to mitigate this bias. (2) Conceptually, the role of outpatient visits on readmission is substantially attenuated in patients discharged to institutional rehabilitation. The average length of stay in a skilled nursing facility or acute rehabilitation facility averages >17 days and for more than one fourth of cases is >30 days, so there is a limited window for outpatient visits before the
WHAT IS KNOWN
• Readmissions after stroke are common, costly, and burdensome.
• A variety of patient and health system factors predict readmission, but little is known about how to prevent readmission.
WHAT THE STUDY ADDS
• Early outpatient physician follow-up visits after a hospitalization for an acute stroke has a small but significant association with lower readmission rates.
• Both primary care and neurology providers had a similar effect on readmissions.
30-day outcome. (3) There is marked variation in the quality of care provided in these facilities, 26, 27 and, without good measures of quality of care in rehabilitation facilities, it would be impossible to disentangle the effects of outpatient visits from the quality of rehabilitation care. (4) There is marked variation in the utilization of different rehabilitation settings in different regions, and without robust clinical data, it would be difficult to account for this selection in our analyses. Of the 78 345 eligible patients, 64 712 patients (83% of original cohort) had complete data capture included in our 2 fully adjusted models.
The study protocol, which does not rely on human subjects, was deemed not regulated by the University of Michigan Institutional Review Board.
Data and Variables
We used Medicare Inpatient files to identify the cohort (patients with acute ischemic stroke hospitalized from January to November 2012), patient-level and system-level variables, and readmissions. The Medicare Carrier file was used to identify and characterize outpatient visits. Transfers of an index stroke case to another acute care hospital were excluded. Readmission dates were assigned based on the discharge date from the receiving hospital.
Our 2 binary primary predictor variables consisted of whether patients had outpatient visit within 30 days to (1) primary care and (2) neurology. Primary care was defined as general practice, family medicine, internal medicine excluding subspecialist visits, and geriatric medicine. Outpatient visits were defined as visits that occurred after the date of discharge in any noninpatient or emergency department setting. The provider specialty of the outpatient visits (primary care and neurology) was identified from carrier claim billing data. We performed multivariable models assessing what baseline factors were associated with 30-day outpatient visits.
Our binary primary outcome was all-cause 30-day hospital readmission. This was defined as any inpatient visit in a short-stay hospital with an admission date greater than the discharge date of the index hospitalization, regardless of the length of stay. Visits to the emergency room, which did not result in readmission, were identified based on place of service codes and were not counted as a readmission. We documented primary readmission diagnoses.
We accounted for a large array of potential confounders, including patient demographics, comorbidities, clinical characteristics, including life-sustaining measures (percutaneous gastrostomy tube, intubation), regional socioeconomic factors, and hospital characteristics and quality measures. These are listed in Table 1 . Patient demographics, including age, sex, and race, were abstracted from the Inpatient and Medicare Beneficiary Summary Files. Comorbidities were identified using modified Charlson definitions based on data from the index admission. 28 Hospitalization characteristics, such as length of stay and whether a patient received thrombolysis, were defined using previously described methods. 8 Regional socioeconomic factors (segregation index, household income, and high-school graduation rate) were based on countylevel census data and were obtained from the Robert Wood Johnson County Health Rankings and Roadmaps project. 
Statistical Analysis
Descriptive statistics were used to summarize the patient cohort. We evaluated the relationship between outpatient visits and readmissions using Cox models with time of follow-up visits specified as a time-dependent variable while accounting for clustering at the hospital level. If patients had a second stroke within 30 days, they were still only counted once in the cohort, and the second stroke was counted as a readmission assuming they were rehospitalized for the second stroke. Death of any cause before 30 days (or 30-day readmission) was censored in these Cox models. We included outpatient office visits as a time-dependent variable given the possibility of survival bias, 31, 32 that is, the time to first office visit could be impacted by a readmission. Separate models were constructed using a variable for primary care and neurology visits individually and another model with variables included to assess their independent effects. Both unadjusted and adjusted models were generated. We adjusted for patient demographics, comorbidities, hospital-level performance on all Hospital Compare performance measures, stroke volume, and all regional socioeconomic variables. All variables were included regardless of statistical significance; we did not use any model-based variable selection procedures.
We performed a variety of sensitivity analyses. First, given the missing data in our socioeconomic variables and to assess the effect of each type of variable, we performed serial model building. To this end, we conducted Cox proportional hazard models including only the primary predictor plus age, then added comorbidities and hospitalization characteristics, then added quality measures, then finally, the fully adjusted model adding socioeconomic variables. Second, we performed competing risk analysis. This analysis was conducted because of the possibility that mortality within 30 days of discharge could prevent 30-day outpatient follow-up and readmission, and thus, early postdischarge mortality could be important relative to our small primary effect size. Whereas Cox regressions use the survival function to calculate the probability of surviving beyond a given time and do not account for the competing nature of multiple causes of the same event, competing risk analysis uses the cumulative incidence function to estimate the marginal probability of each competing event, such as mortality. Given this alternative approach to events that would have been censored in Cox regressions, competing risk analysis may more accurately assess the impact of outpatient visits on readmissions. Competing risk models were adjusted for all of the same variables as the fully adjusted Cox models. Third, we performed a model assessing preventable readmission as the outcome using definitions described by Lichtman et al 33 according to the Agency for Healthcare Research and Quality Prevention Quality Indicators. These include conditions relevant to elderly patients including chronic lung disease, diabetes mellitus, cardiovascular indications, and certain acute conditions, such as infections and dehydration. This analysis was conducted to assess whether primary care and neurology would have a differential effect on preventable readmissions rather than overall readmissions. For example, it is possible that primary care might be more effective at reducing ambulatory-sensitive conditions as defined by the Agency for Healthcare Research and Quality (heart failure, pneumonia, diabetes mellitus, etc), which tend to be more likely managed by primary care physicians.
All analyses were performed using Stata statistical software, release 14 (StataCorp LP, College Station, TX).
RESULTS

Summary of Study Population and Key Variables
We display a flowchart of our cohort construction in Figure 1 . There were 270 725 primary short-stay stroke discharges. After applying exclusions for discharge to care facilities, unavailability of adequate ‡Selected regional socioeconomic factors are defined as follows. Segregation index measures the degree to which the minority group is distributed differently than whites across census tracts. It ranges from 0% (complete integration) to 100% (complete segregation) where the value indicates the percentage of the minority group that would need to move to create an equal population distributed exactly like whites. Graduation rate refers to high-school graduation rate. Medicare data, and discharge in the final month of the year (given that they did not have the chance for a 30-day readmission within 2012), 78 345 patients remained. Of these, 64 712 had complete data available for our final fully adjusted models. Nearly all missing data were because of missing regional socioeconomic data comprising household income, segregation index, and high-school graduation rate. Missing socioeconomic data were because of either true missing values or else imperfect linkages between the measured county-level measures and patient-level zip measures. Patient demographics are displayed in Table 1 . The overall 30-day readmission risk was 7372/78 345=9.4%. For the 7372 patients who were readmitted within 30 days of discharge, the median number of days until readmission was 14 (interquartile range, 7-21). For the 47 896 (61%) patients who had a primary care visit within 30 days of discharge, the median number of days until the first primary care visit was 7 (interquartile range, 4-13). For the 12 536 (16%) patients who had a neurology visit within 30 days of discharge, the median days until first neurology visit were 15 (interquartile range, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . The full distribution for each of these variables is depicted in Figure 2 .
A variety of factors were associated with readmission as listed in Table 1 . These included most comorbidities, life-sustaining treatments, such as requiring a percutaneous endoscopic gastrostomy tube and intubation, hospitalization characteristics (ie, length of stay and transfer status), and several regional factors. A variety of factors, which might have been plausibly related to the outcome, were found to be not significantly related to readmissions, including age, sex, hospital stroke volume, and most stroke quality measures. We tabulated the most common causes for readmission in Table 2 . We list those diagnoses comprising at least 1% of readmissions for any of the 3 listed groups (overall, those with 30-day primary care visits and those with 30-day neurology visits) for display purposes. The most frequent types of readmissions included cerebrovascular, cardiovascular, and infectious primary diagnoses. Diagnoses appeared roughly similar between groups.
Association Between Patient, Hospital, and Regional Factors With Outpatient Visits
We performed separate models to identify the factors associated with 30-day primary care and neurology visits. Results are found in Table I in the Data Supplement. These odds ratios were produced from fully adjusted models, including all variables in Table 1 . Older age, female sex, uncomplicated diabetes mellitus, and discharge with home health were associated with increased 30-day primary care visits but decreased neurology visits. Black race, numerous comorbidities (ie, myocardial infarction, congestive heart failure, chronic obstructive lung disease, hemiplegia, and metastatic malignancy), gastrostomy tube placement, and length of stay were associated with reduced visits for both provider types. Of note, per the residual intra- class correlation for each model, 6% of the variance for primary care visits and 15% of the variance for neurology visits was at the hospital level. This suggests that hospital correlates with other factors, which may predict readmission. Tables 3 and 4 describe readmission risk in more detail according to whether patients received 30-day outpatient physician follow-up for primary care and neurology, respectively. These tables include Cox proportional hazards regressions adjusted only for age and also models fully adjusted for all variables noted in the 
Association Between 30-Day Outpatient Follow-Up Visit and 30-Day Readmissions
Sensitivity Analyses
Given that 17% of patients had at least 1 missing variable thus excluded from the final fully adjusted models, we performed serial models to better under- stand the effect of missing data. Results are displayed in Table II in the Data Supplement. The n values for each model describe the number of patients with complete data capture for the listed variables. Nearly all missing values were because of regional socioeconomic variables (segregation index, household income, and graduation rate), and little data were missing because of any other variables. Our main adjusted HR was essentially unchanged when performing the displayed serial model building, including the final step when regional variables were included or excluded.
To overcome potential issues related to censorship and competing risk as mentioned in the Methods section, we performed competing risk analysis. The following provides a description of patients who died before the opportunity for outpatient follow-up or readmission to consider the potential effect of censorship because of the competing risk of death within 30 days. Of the 1365 (1.7% of total sample of 78 345) patients who died within 30 days of discharge, 682 had neither 30-day primary care nor 30-day readmission before death, 166 had both, 312 were readmitted but did not have a primary care visit, and 205 had a primary care visit but no readmission. Examined in a different way, of the 70 973 patients who were not readmitted within 30 days (ie, could have been censored in a Cox regression had they not been readmitted because of early death), 1.3% (n=887) died within 30 days and thus may not have had the opportunity for readmission. Using competing risk analysis, despite the above counts of patients who died before 30 days, 30-day primary care (HR, 0.98; 95% CI, 0.97-0.98) and neurology (HR, 0.98; 95% CI, 0.97-0.98) visits had nearly identical effects on 30-day readmission as in the Cox regressions.
We next performed analysis similar to that presented in the study by Lichtman et al 33 regarding potentially preventable readmissions. Of the 7370 patients with 30-day readmissions in our sample whose preventability could be assessed (of 7372 total readmissions), 1189 (16%) were considered preventable by the criteria used in the study by Lichtman et al. Table 5 reports models similar to our main analyses (shown in Tables 3 and 4), except in Table 5 , the regression outcome is whether a patient had a preventable readmission according to definitions used in the study by Lichtman et al. CI indicates confidence interval; HR, hazard ratio; and tPA, tissue-type plasminogen activator. *Adjusted for demographics (age, sex, and race), comorbidities (myocardial infarction, congestive heart failure, dementia, chronic obstructive pulmonary disease, rheumatological disorders, peptic ulcer disease, mild liver disease, moderate-severe liver disease, uncomplicated diabetes mellitus, complicated diabetes mellitus, hemiplegia, renal disease, cancer, and AIDS), life-sustaining treatment (percutaneous gastrostomy tube placement, tracheostomy, intubation, and hemodialysis), hospital characteristics (length of stay, tPA administration, discharge with home health, transfer, and stroke volume), all hospital stroke quality measures, and additional regional socioeconomic factors (graduation rate, household income, and segregation index).
DISCUSSION
Effective strategies to achieve the important goal of reducing poststroke readmissions are largely unknown. Prior research in acute stroke has not identified consistent modifiable patient-or system-level factors associated with readmissions, 1 and thus, it has proven challenging to design systems of care to meaningfully impact readmissions. [34] [35] [36] Although we found that early outpatient visits are associated with a reduction in readmission rates, the magnitude of this effect is small. Thus, novel approaches will be needed to reduce readmission rates. Given that only 61% and 16% of patients visit a primary care provider or neurologist, respectively, within 30 days, though, our data suggest that there may be a small opportunity to reduce readmission and potentially improve other outcomes, by improving access to early outpatient care.
Still, even a small reduction in readmission rates by a relative low-cost strategy, such as this, could have a nontrivial economic impact. Jencks et al 2 estimate the cost to Medicare of all unplanned readmissions in 2004 was $17.4 billion. Kind et al 3 estimated the bounce-back cost for patients with acute stroke. They calculated for zero bounce backs adjusted predicted payments ranged from $1667 at the 10th percentile to $35 854 at the 90th, patients with 1 bounce back had payments ranging from $2726 to $45 404, and patients with ≥2 bounce backs had payments ranging from $3753 to $53 766 at the 10th and 90th percentiles, respectively.
Numerous possible explanations for the small effect size of early outpatient follow-up on readmission exist. One possible explanation is that only a small percentage of readmissions after stroke may be truly preventable, in which case, it may not be worth large-scale implementation of rapid outpatient visits. 13, 33 Many nonmodifiable factors likely exist in an elderly poststroke population with high baseline risk of vascular and nonvascular events even with guideline-based secondary prevention. It should also be mentioned that the optimal readmission rate is unknown but unlikely to be zero. Even though readmissions are costly and often undesirable, it is preferable to appropriately rehospitalize a patient with additional inpatient needs rather than provide continued inadequate outpatient care, and at least 1 study documented increased readmissions with increased outpatient access. 37 Furthermore, even if a physician provides an effective treatment plan, system barriers and socioeconomic factors may prevent a patient from executing a physician's recommendations. Another possible explanation for our small effect size is that a single early contact with an outpatient provider may be inadequate to meaningfully alter readmission rates given the focus of other studies on longitudinal multidisciplinary interventions. [38] [39] [40] [41] [42] [43] [44] [45] A final explanation for our effect size could be that the true effect is larger than detected in this study, but the association was distorted by unmeasured confounding. Sicker patients may be more likely to attend early outpatient visits and be at higher risk for readmission, which would bias the measured association toward the null. Interestingly, in our study, length of stay was slightly shorter for those patients who were readmitted. One may have hypothesized that patients with longer lengths of stay because of higher acuity or additional complications may have been more likely to be readmitted, but this was not the case in our analysis. It is possible that premature hospital discharge could be a driver of readmission.
Some of the more successful care models in stroke and other conditions that aim to reduce readmissions have evaluated multidisciplinary outpatient teams with early or longitudinal interventions. [38] [39] [40] [41] [42] [43] [44] [45] For example, a recent observational study found that attending a nursing-led Transitional Stroke Clinic with added interim patient phone contact was associated with significantly lower 30-day (though not 90-day) readmission. 46 Expedited outpatient care would make intuitive sense as an optimizable target to reduce readmissions through a variety of plausible mechanisms, such as encouraging adherence to secondary prevention measures, addressing existing or new symptoms developing after dis- Table 3 .
charge, coordinating therapies, and ensuring rapid follow-up of issues identified by inpatient providers, such as pending diagnostic testing. The main drivers of poststroke readmission include recurrent stroke, coronary artery disease, and infection, 4 all of which would seem plausibly reducible with optimal medical care, including early outpatient follow-up.
Our study has numerous strengths. We addressed survival bias through our statistical analysis. Survival bias (if not addressed) could make an intervention appear falsely effective. This overestimation of effect would occur by counting person-time before an outpatient visit as intervention person-time, thus inflating the denominator and artificially lowering the early followup group's event rate, despite the fact that office visits could have only possibly been effective during or after a visit. Thus, the seemingly large difference between our sample's risk of readmission for those who did versus did not have a 30-day primary care (6.6% versus 13.8%) or neurology (4.5% versus 10.4%) visit likely overestimates the effect size if survival bias is not considered. Our time-dependent covariate model addressed this issue by contributing time before the office visit as nonintervention person-time. 31, 32 We also had a large sample size of a nationally representative Medicare sample. Finally, we addressed confounding by incorporating a wide variety of potential confounders at numerous levels to account for additional important confounders regarding the patient's discharge environment and proxy severity measures (ie, length of stay, intubation, tPA (tissue-type plasminogen activator) administration, and the need for postdischarge home health).
Our study has several limitations. First, large administrative data do not capture the content of a given outpatient visit, so the mechanism underlying our studied relationship cannot be definitively determined. Additional research may focus on what elements of a brief outpatient visit may be considered the highest value in reducing readmissions and thus how to make outpatient visits more effective. Second, the potential role of unmeasured confounding as discussed above may bias our findings in either direction. Our data set does not contain the National Institutes of Health stroke scale for individual patients, which is an important marker of stroke severity. Regional measures likely do not adjust for all potential effects of socioeconomic factors at the individual level, and unmeasured differences in baseline risk almost certainly still exist. Third, although our study has excellent generalizability in the sense that our nationwide population was drawn from patients across socioeconomic and geographic strata, the Medicare population may not generalize to those <65 years of age. Limited studies including stroke survivors have documented differing readmission rates according to discharge location, 7,47,48 and our results do not inform the effect of outpatient visits on readmission for the large and important patient population discharged to postacute care facilities. Additional studies of the population discharged to postacute care facilities are thus likely needed. Fourth, our fully adjusted models excluded 17% of the initial population (initial population, 78 345; analyzed population, 64 712) because of missing data primarily in socioeconomic variables, though serial model building, such as removing these variables from our model (with resultant little missing data), produced similar results. Finally, although our time-dependent analysis reduced bias, we do acknowledge that measuring the outcome and exposure on the same timescale adds some conceptual complexity. Our goal was to understand how much real-world variation in outpatient care may influence readmission rates on the timescale (30 days) measured by current quality measures. Our findings, then, do not preclude the possibility that outpatient visits may have a larger association with readmissions if timing (and other features) was optimized.
CONCLUSIONS
In conclusion, 30-day outpatient follow-up was associated with a small but significant reduction in hospital readmission among elderly patients with stroke who were discharged from the hospital to home. Our data identify a potentially underutilized target for future interventions aimed at reducing the cost and burden of stroke. However, the magnitude of effect was small, and thus, future work should focus on mechanisms to enhance outpatient care. Additional directions of inquiry could include identifying what provider types may have the largest impacts on specific readmission diagnoses at various time points in different patient populations, clarifying the mechanism through which outpatient care might ultimately affect health maintenance and how to make such visits the most useful to patients, and studying patients discharged to rehabilitation facilities.
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